Myocardial fibrosis in transforming growth factor‐β1 (TGF‐β1) transgenic mice is associated with inhibition of interstitial collagenase
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Background TGF‐β 1 mediates effects on fibroblast proliferation and collagen synthesis in the myocardium. The extracellular matrix remodeling depends on the fibrillar collagen degrading matrix metalloproteinases (MMPs) and their inhibitors (TIMPs). The in vivo effects of TGF‐β 1 on the MMP/TIMP system in TGF‐β 1 overexpressing transgenic mice were studied. Methods Male Alb/TGF‐β 1(cys 223,225 ser) transgenic mice (TG) and nontransgenic controls (C; 8 weeks) were examined. Protein expression of collagen type I, ‐III, interstitial collagenase (Int Coll), MMP‐2, ‐9, TIMP‐1, ‐2, ‐4 and TGF‐β 1 as well as enzyme activity (MMP‐2, ‐9) were measured (Western blots, zymographic assays). mRNA expression of the interstitial collagenase and MMP‐9 was studied with the Light‐Cycler based real‐time PCR. Results Overexpression of TGF‐β 1 resulted in a 10‐fold increase in plasma and a seven‐fold increase in myocardial TGF‐β 1 concentrations. Relative heart weights increased (mg g−1: 7·8 ± 0·4 vs. 4·8 ± 0·6, n= 6; P < 0·01) in TG compared to C. Collagen type I and III increased in TG (1·9‐fold and 1·7‐fold) compared to controls. Interstitial collagenase protein activity (− 91%) and mRNA expression (−75%) in TG were reduced (P < 0·05–P < 0·001). Gelatinase (MMP‐2, MMP‐9) expression and activity were not significantly alterated. MMP‐inhibitors were increased 2·5‐fold (TIMP‐1, ‐4) and 6‐fold (TIMP‐2) in TG. Conclusions TGF‐β 1 produces myocardial fibrosis in vivo. This effect is not only produced by a stimulation of matrix protein formation: a complex regulation of MMP and TIMP interaction, namely decrease of expression and activity of interstitial collagenase and an enhanced inhibition by increased levels of TIMPs, are involved. These mechanisms are optional targets for therapeutic interventions in myocardial diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Left Ventricular Hypertrophy: Pathogenesis, Detection, and Prognosis
Lorell, B. H., & Carabello, B. A. (2000) · Circulation · doi:10.1161/01.cir.102.4.470 · Cited by 1,232
Edwards, D. R., Murphy, G., Reynolds, J. J., Whitham, S. E., Docherty, A. J., Angel, P., & Heath, J. K. (1987) · The EMBO Journal · doi:10.1002/j.1460-2075.1987.tb02449.x · Cited by 1,221
Cited by
The pathogenesis of cardiac fibrosis
Kong, P., Christia, P., & Frangogiannis, N. G. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1349-6 · Cited by 1,567
Frangogiannis, N. G. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvaa324 · Cited by 1,229
TGF-β signaling in health, disease and therapeutics
Deng, Z., Fan, T., Xiao, C., Tian, H., Zheng, Y., Li, C., & He, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01764-w · Cited by 1,168
Cardiac fibrosis: Cell biological mechanisms, molecular pathways and therapeutic opportunities
Frangogiannis, N. G. (2019) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2018.07.001 · Cited by 841
TGF-β and fibrosis in different organs — molecular pathway imprints
Pohlers, D., Brenmoehl, J., Löffler, I., Müller, C. K., Leipner, C., Schultze-Mosgau, S., Stallmach, A., Kinne, R. W., & Wolf, G. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.06.004 · Cited by 576
Metadata
- Authors
- Seeland, U., Haeuseler, C., Hinrichs, R., Rosenkranz, S., Pfitzner, T., Scharffetter‐Kochanek, K., & Böhm, M.
- Venue
- European Journal of Clinical Investigation
- Publisher
- Wiley
- Published
- 2002-05
- Volume
- 32
- Issue
- 5
- Pages
- 295-303
- ISSN
- 0014-2972 (ISSN-L)
- 1365-2362
- OpenAlex
- W1974777700
- Cited by
- 127
- References
- 2
- FWCI
- 4.57
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Myocardial fibrosis in transforming growth factor‐β1 (TGF‐β1) transgenic mice is associated with inhibition of interstitial collagenase. https://app.cochat.ai/papers/10.1046/j.1365-2362.2002.00985.x
- The paper
- Seeland, U., Haeuseler, C., Hinrichs, R., Rosenkranz, S., Pfitzner, T., Scharffetter‐Kochanek, K., & Böhm, M. (2002). Myocardial fibrosis in transforming growth factor‐β1 (TGF‐β1) transgenic mice is associated with inhibition of interstitial collagenase. European Journal of Clinical Investigation. https://doi.org/10.1046/j.1365-2362.2002.00985.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.